Patent · US Active

Devices and methods for antibiotic susceptibility testing

US11952636B2 · kind B2 · utility

0Cited by
109References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 6, 2022
Grant dateApr 9, 2024
Priority date
Expiry dateMay 6, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2021/786
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The disclosure relates generally to molecular diagnostic devices configured to amplifying a single nucleotide polymorphism (SNP) locus and discriminate between two or more allelic variants of the SNP, indicating presence or absence of a target allele. In some embodiments, the molecular diagnostic devices are capable of detecting, at point-of-care, SNPs associated with resistance or susceptibility to antibiotic treatment of organism infections. In other aspects, the disclosure provides methods of treatment for disease or disorders (e.g. organism infections) where treatment is guided by presence or absence of an allele at a SNP locus as determined by such molecular diagnostic devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.